Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M516Revenue $M158Net Margin (%)-20.7Altman Z-Score0.5
Enterprise Value $M693EPS $-1.4Operating Margin %-10.8Piotroski F-Score5
P/E(ttm)--Beneish M-Score152Pre-tax Margin (%)-20.2Higher ROA y-yY
Price/Book3.410-y EBITDA Growth Rate %--Quick Ratio2.5Cash flow > EarningsY
Price/Sales2.75-y EBITDA Growth Rate %-19.1Current Ratio3.6Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-12.9Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-28.6Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M28.6ROIC % (ttm)-29.9Gross Margin Increase y-yN

Gurus Latest Trades with AEGR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AEGRMichael Price 2014-12-31 Sold Out -1%$19.66 - $35.02
($25.02)
$ 18.05-28%Sold Out0
AEGRGeorge Soros 2014-12-31 Sold Out -0.01%$19.66 - $35.02
($25.02)
$ 18.05-28%Sold Out0
AEGRJoel Greenblatt 2014-12-31 Sold Out $19.66 - $35.02
($25.02)
$ 18.05-28%Sold Out0
AEGRGeorge Soros 2014-09-30 Buy 0.01%$26.93 - $35.65
($30.96)
$ 18.05-42%New holding25,000
AEGRJoel Greenblatt 2014-09-30 Buy $26.93 - $35.65
($30.96)
$ 18.05-42%New holding10,964
AEGRMichael Price 2014-03-31 Buy 1.1%$43.65 - $73.75
($59.26)
$ 18.05-70%New holding200,000
AEGRGeorge Soros 2012-06-30 Sold Out -0.01%$11.76 - $16.96
($14.02)
$ 18.0529%Sold Out0
AEGRGeorge Soros 2011-06-30 Buy 0.01%$15.29 - $21.85
($17.62)
$ 18.052%New holding37,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AEGR is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


AEGR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Fitzpatrick Mark J.CFO 2014-08-19Buy1,150$30.64-41.09 view
Beer Marc DCEO 2014-07-31Buy10,000$33.65-46.36 view
Beer Marc DCEO 2014-06-03Buy10,000$30.12-40.07 view
Beer Marc DCEO 2014-05-27Buy10,000$31.59-42.86 view
Beer Marc DCEO 2014-05-20Buy10,000$30.53-40.88 view
Beer Marc DCEO 2014-05-08Buy30,000$35.31-48.88 view
VANLENT ANNEDirector 2014-05-08Buy4,000$33.78-46.57 view
Fraser CraigPres., US/Int. Comm. & Manuf. 2014-04-30Sell2,250$43.55-58.55 view
Fraser CraigPres., US/Int. Comm. & Manuf. 2014-03-31Sell2,250$46.2-60.93 view
Sumeray MarkChief Medical Officer 2014-03-14Sell2,000$51.34-64.84 view

Quarterly/Annual Reports about AEGR:

    News about AEGR:

    Articles On GuruFocus.com
    Gilead Sciences Releases Impressive Results for Hepatitis C Drug Nov 12 2014 
    Weekly CEO Buys Highlight: APD, OCUL, CNMD, OPK, AEGR Aug 04 2014 
    Weekly CEO Buys Highlight: GEO, TRUE, BANC, AEGR, CLMS Jun 02 2014 
    Three CEOs Reporting Large Insider Buys May 22 2014 
    Four CEOs Reporting Large Insider Buys May 09 2014 
    100 Stocks at All-Time Highs | 60 Dividend Stocks Below the Results Feb 19 2013 
    My 3 Favorite Dividend Stocks at All-Time-Highs | Stock List Dec 27 2012 
    Weekly CFO Buys Highlight: RXN, XBKS, STAG, AEGR, PZG Apr 02 2012 

    More From Other Websites
    AEGERION PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers,... Jun 29 2015
    Notable option activity in equities Jun 29 2015
    Aegerion Pharmaceuticals Appoints Gregory Perry as Chief Financial Officer Jun 25 2015
    Aegerion Pharmaceuticals Appoints Gregory Perry as CFO Jun 25 2015
    Aegerion Pharmaceuticals Appoints Gregory Perry as Chief Financial Officer Jun 25 2015
    Broadfin Capital Thinks ContraFect Corp (CFRX) Can Prevent 25% of Deaths Jun 22 2015
    Edited Transcript of AEGR presentation 13-May-15 8:00pm GMT Jun 17 2015
    Aegerion Pharmaceuticals Announces Key Additions to Medical Affairs and Drug Safety Jun 16 2015
    Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program Jun 11 2015
    Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program Jun 11 2015
    AEGERION PHARMACEUTICALS, INC. Files SEC form 8-K/A, Change in Directors or Principal Officers May 29 2015
    Aegerion Pharmaceuticals Announces Presentation at the Jefferies 2015 Healthcare Conference May 27 2015
    Aegerion Pharmaceuticals Announces Presentation at the Jefferies 2015 Healthcare Conference May 27 2015
    Aegerion's Juxtapid Successful in Phase III Japanese Study - Analyst Blog May 27 2015
    Aegerion Pharmaceuticals Achieves Primary Endpoint in Phase III Study of Lomitapide in Japanese... May 26 2015
    Aegerion Pharmaceuticals Achieves Primary Endpoint in Phase III Study of Lomitapide in Japanese... May 26 2015
    AEGERION PHARMACEUTICALS, INC. Financials May 16 2015
    CFO Moves: Arista Networks, 3D Systems, Aegerion Pharmaceuticals May 15 2015
    AEGERION PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other... May 14 2015
    Aegerion Pharmaceuticals Announces Resignation of Chief Financial Officer May 14 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK